TY - JOUR
T1 - Participatory development of a 3D telemedicine system during COVID
T2 - the future of remote consultations
AU - 3DTM (3D Telemedicine) Collaborative research group
AU - Lo, Steven
AU - Fowers, Spencer
AU - Darko, Kwame
AU - Spina, Thiago
AU - Graham, Catriona
AU - Britto, Andrea
AU - Rose, Anna
AU - Tittsworth, David
AU - McIntyre, Aileen
AU - O'Dowd, Chris
AU - Maguire, Roma
AU - Chang, Wayne
AU - Young, David
AU - Hoak, Amber
AU - Young, Robin
AU - Dunlop, Mark
AU - Ankrah, Levi
AU - Messow, Martina
AU - Ampomah, Opoku
AU - Cutler, Ben
AU - Armstrong, Roma
AU - Lalwani, Ruchi
AU - Davison, Ruairidh
AU - Bagnall, Sophie
AU - Hudson, Whitney
AU - Shepperd, Mike
AU - Johnson, Jonny
PY - 2023/12/1
Y1 - 2023/12/1
N2 - The COVID pandemic brought the need for more realistic remote consultations into focus. 2D Telemedicine solutions fail to replicate the fluency or authenticity of in-person consultations. This research reports on an international collaboration on the participatory development and first validated clinical use of a novel, real-time 360-degree 3D Telemedicine system worldwide. The development of the system - leveraging Microsoft's Holoportation™ communication technology - commenced at the Canniesburn Plastic Surgery Unit, Glasgow, in March 2020. The research followed the VR CORE guidelines on the development of digital health trials, placing patients at the heart of the development process. This consisted of three separate studies - a clinician feedback study (23 clinicians, Nov-Dec 2020), a patient feedback study (26 patients, Jul-Oct 2021), and a cohort study focusing on safety and reliability (40 patients, Oct 2021-Mar 2022). "Lose, Keep, and Change" feedback prompts were used to engage patients in the development process and guide incremental improvements. Participatory testing demonstrated improved patient metrics with 3D in comparison to 2D Telemedicine, including validated measures of satisfaction (p
AB - The COVID pandemic brought the need for more realistic remote consultations into focus. 2D Telemedicine solutions fail to replicate the fluency or authenticity of in-person consultations. This research reports on an international collaboration on the participatory development and first validated clinical use of a novel, real-time 360-degree 3D Telemedicine system worldwide. The development of the system - leveraging Microsoft's Holoportation™ communication technology - commenced at the Canniesburn Plastic Surgery Unit, Glasgow, in March 2020. The research followed the VR CORE guidelines on the development of digital health trials, placing patients at the heart of the development process. This consisted of three separate studies - a clinician feedback study (23 clinicians, Nov-Dec 2020), a patient feedback study (26 patients, Jul-Oct 2021), and a cohort study focusing on safety and reliability (40 patients, Oct 2021-Mar 2022). "Lose, Keep, and Change" feedback prompts were used to engage patients in the development process and guide incremental improvements. Participatory testing demonstrated improved patient metrics with 3D in comparison to 2D Telemedicine, including validated measures of satisfaction (p
KW - remote consultation
KW - telemedicine
KW - COVID-19
KW - 3 dimensional
KW - plastic surgery
KW - realism
U2 - 10.1016/j.bjps.2022.10.012
DO - 10.1016/j.bjps.2022.10.012
M3 - Article
C2 - 36890078
SN - 1748-6815
VL - 87
SP - 479
EP - 490
JO - Journal of Plastic, Reconstructive & Aesthetic Surgery
JF - Journal of Plastic, Reconstructive & Aesthetic Surgery
ER -